MAPT and Alzheimer disease: Some controls in EMIF-AD MBD had increased tau levels, which may have contributed to low memory scores in these individuals, as tau can impair synaptic plasticity and cause synaptic damage (Hu et al., n.d.; [17, 30, 33]).